GT Biopharma, Inc. issued the following announcement on Nov. 24.
GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® platform, today announced that Michael Breen, Executive Chairman and Dr. Greg Berk, President of R&D, Chief Medical Officer and Interim Chief Executive Officer will be hosting a Management Update Conference call on Tuesday, November 30th at 4:30PM Eastern Time.
To join the live webcast of the call and view the accompanying slide presentation, please use this link:
https://viavid.webcasts.com/starthere.jsp?ei=1516135&tp_key=68a3021ba2
Those who wish to dial in by phone for the audio portion only of the event may do so at:
PARTICIPANT TOLL FREE DIAL-IN: 1-877-407-9039
PARTICIPANT INTERNATIONAL DIAL-IN: 1-201-689-8470
CONFERENCE ID: 13725380
An archived replay of the webcast will be available on the Company's website by visiting:
https://www.gtbiopharma.com/news-media/presentations
Original source can be found here.
Source: GT Biopharma, Inc.
Alerts Sign-up